CD4 and myeloid sarcoma: A significant decrease in CD4 and CD8 T cells, as well as MAITs, upon FTY720 administration, as shown in Fig. 4, suggested that CCR7+ MAITs could be present in MS, probably during the acute relapse stage or in the secondary lymphoid organs, which we did not examine in this study.